跳至主要内容
临床试验/NCT01519739
NCT01519739已完成不适用

Clinical Evaluation of Mediguide System in CRT Implants

Abbott Medical Devices0 个研究点目标入组 15 人开始时间: 2012年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
主要终点
The performance of the MediGuide™ system during CRT implant

研究概览

简要总结

The purpose of this study is to evaluate the safety and performance of the MediGuide™ system during CRT implants.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet clinical indication for implantation of an SJM CRT system according to the current European Society of Cardiology (ESC) Guidelines for cardiac and resynchronization therapy
  • Receiving a new implant or undergoing an upgrade from an existing ICD or pacemaker implant with no prior LV lead placement
  • Ability to provide informed consent for study participation and are willing and able to comply with the prescribed follow-up tests and schedule of evaluations

排除标准

  • Currently participating in any other clinical study
  • Have prosthetic valves
  • Are pregnant or planning pregnancy in the next 1 month
  • Are less than 18 years of age
  • Have ventricular tachyarrhythmias resulting from transient or correctable factors such as drug toxicity, electrolyte imbalance, or acute myocardial infarction

研究组 & 干预措施

MediGuide Arm

Experimental

干预措施: MediGuide™ (Device)

结局指标

主要结局

The performance of the MediGuide™ system during CRT implant

时间窗: 1 month post CRT implant

Performance will be assessed in terms occurence of adverse events, easy of use and potential benefits.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Clinical Evaluation of Mediguide System in Cardiac... | 临床试验